Avallon Labs, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Avallon Labs, Inc. - overview

Established

2025

Location

Brooklyn, NY, US

Primary Industry

Software

About

Avallon Labs, Inc. is a US-based technology company specializing in automating claims operations to enhance productivity and reduce costs within the insurance sector. Founded in 2025 in Brooklyn, US, Avallon Labs, Inc. focuses on developing solutions for claims operations.


The company successfully raised USD 4. 6 mn in Seed funding on November 6, 2025, led by Frontline, with participation from Y Combinator, 1984, Liquid 2 Ventures, and Booom. This was their first deal since establishment, targeting investors interested in innovative insurance technology. Avallon offers an innovative solution designed to automate claims operations, significantly enhancing productivity and reducing operational costs.


The core product suite includes features such as a claims intaker that captures new losses through multiple channels—phone, email, or file upload—enabling filing with zero manual data entry. Additionally, the Case Status Receptionist answers inbound status inquiries with real-time updates, while the Third-party Reacher auto-dials relevant stakeholders to log responses. Avallon’s technology also incorporates Context-Aware AI to facilitate decision-making throughout the claims process, ensuring efficient management of workflows. The company serves a diverse client base across various sectors, including Workers Compensation, Property & Casualty, and Health insurance, primarily targeting markets in the United States and Europe.


Their offerings are geared towards administrators and claims teams looking to streamline operations and eliminate repetitive tasks. Avallon operates a revenue model that primarily focuses on subscriptions and partnerships within the insurance industry, targeting carriers, managing general agents (MGAs), and third-party administrators (TPAs). The company’s flagship products, centered around its AI agents for claims operations, are integrated into clients' existing systems, allowing for seamless automation of claims processes. Clients engage with Avallon under structured agreements that typically encompass monthly or annual subscription fees for access to their comprehensive suite of services.


The pricing structure is designed to align with the scale of integration and the specific requirements of each client, ensuring flexibility in service delivery. By leveraging their advanced technology, Avallon facilitates ongoing transactions that enhance claims management efficiency for their clients. In November 2025, Avallon Labs, Inc. raised USD 4.


6 million in Seed funding led by Frontline, with participation from other investors including Y Combinator, 1984, Liquid 2 Ventures, and Booom. The funding will be used to hire talent and accelerate product development, aiming to expand into a full AI platform applicable for all insurance lines and healthcare. The company plans to launch new products that enhance its automation capabilities and is targeting expansion into additional European markets by the end of 2026.


Current Investors

Y Combinator, Frontline, Liquid 2 Ventures

Primary Industry

Software

Sub Industries

Analytics & Performance Software, Information Services

Website

www.avallon.ai

Verticals

Artificial Intelligence, Cloud Computing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.